Skip to main content
Equibles
OTLK logo

OTLK · Outlook Therapeutics, Inc. · Proposed Sales

Track OTLK — free

Use OTLK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OTLK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.65 +0.01 (+0.95%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 18, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Because our cash and cash equivalents, together with $51.1 million of net proceeds from our August 2026 Offering, will not be adequate to fund our currently planned operations through at least the 12 months from the date of this Quarterly Report, there is substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 18, 2026
Market Cap
$156.76M
Shares
243.45M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1649989 CUSIP 69012T305 13F (30d) 41 filings 41 filers Visit website Investor relations